|  | with cerebral complications n = 20 | without cerebral complications n = 11 | p value |
---|---|---|---|---|
Operative indication | Heart failure unresponsive to medical therapy (%) | 8 (40) | 10 (91) | 0.025 |
High embolic risk (%) | 8 (40) | 1 (9) | ||
Persistent infection (%) | 2 (10) | 0 | ||
Perivalvular extension (%) | 2 (10) | 0 | ||
Emergency surgery (%) | 7 (35) | 1 (9) | 0.086 | |
Minimally invasive cardiac surgery (%) | 11 (55) | 8 (73) | 0.33 | |
Operation time (minutes) | 372 (210–792) | 247 (219–452) | 0.085 | |
CPB (minutes) | 198 (101–410) | 177 (82–248) | 0.046 | |
ACC (minutes) | 115 (58–213) | 94 (46–136) | 0.071 | |
Maximum ACT (seconds) | 502 (388–628) | 485 (405–569) | 0.96 | |
Maximum mean arterial blood pressure (mmHg) | 63 (49–78) | 70 (50–87) | 0.0011 | |
ICU stay (days) | 3 (1–28) | 2 (2–15) | 0.84 | |
Hospitalization (days) | 29 (14–43) | 15 (8–84) | 0.23 | |
Neurological outcomes (%) | 1 (5) | 1 (9) | 0.66 | |
Tracheostomy (%) | 1 (5) | 1 (9) | 0.66 | |
Pacemaker implantation (%) | 2 (10) | 0 | 0.18 | |
Renal complication (%) | 0 | 0 | Â | |
Pathological results (%) | 19 (95) | 5 (45) | 0.0026 | |
Early mortality (%) | 0 | 0 | Â | |
Late mortality (%) | 1 (5) | 0 | 0.34 | |
MACCE (%) | 2 (10) | 2 (18) | 0.52 | |
Events related to infection (%) | 2 (10) | 3 (27) | 0.22 |